Together with Professor Resia Pretorius, we have been studying the role of fibrin amyloid microclots in the phenomena of Long COVID (and related post-infection diseases). All of the papers (including many on iron dysregulation and the role of infections) are on the group’s Publications page. Following considerable earlier work using electron microscopy (that uncovered ‘dense matted deposits’, that…
Episode 33 of the Long Covid Podcast is a chat with Professors Resia Pretorius & Douglas Kell about their discovery of microclots & hyperactive platelets in the blood of people with Long Covid, what this means and more about their research into this. We cover a whole load of amazing stuff from causes to possible…
From a lay person’s perspective, if the “spike protein” is known to cause inflammation and micro-blood clots, it might cause damage similar to diabetes or circulatory diseases – which can damage to eyesight. As with every other complication of these injections, the extent of “what we do not know” is a crime in itself. None…
‘This is a big deal to those young people, they joined to get those benefits,” Tankersley said. “They are petrified of losing those benefits.
“Given the large reservoir of potential antibodies in the healthy population, this may represent a modest concern for future vaccine design.”
Lawyer Julian Gillespie is standing up to Australia’s Secretary of Health in Federal Court against the dangerous and deadly shots, warns of big pharma’s influence over politicians and medical authorities, and new oppressive powers being legislated, and calls out the Australian government for ignoring the Pandemic Plan and letting WHO go rogue on the Australian…
A pharmacist can now practice medicine, but a doctor will lose his license for treating COVID patients and vaccine injuries. In 2021, we witnessed one of the most remarkable dynamics unfold in the history of American medicine. An order came down through the corporate pharmacy cartel to start illegally practicing medicine by denying prescriptions written by…
